Amphastar P (AMPH)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $1.25B
Last updated: Nov 17, 2026 at 4:15 PM ET
Amphastar P (AMPH) Statistics
Amphastar P (AMPH) has a market cap of $1.25B and an enterprise value of $1.66B. Its share count is down 8.38% from a year earlier. Its trailing P/E of 10.3x is below its 10-year median of 23.7x.
Total Valuation
Enterprise value is 32.61% above the market cap, as debt exceeds cash.
| Market Cap | $1.25B |
|---|---|
| Enterprise Value | $1.66B |
| Latest price (Nov 17, 2026) | $29.17 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.7x and 1.5x. Its year-end P/E ranged from 8.8x to 86.5x from 2016 to 2025.
| P/E Ratio | 10.3x |
|---|---|
| Forward P/E | 9.0x |
| P/S Ratio | 1.7x |
| Forward P/S | 1.7x |
| P/B Ratio | 1.5x |
| P/TBV Ratio | 7.1x |
| P/FCF Ratio | 8.9x |
| P/OCF Ratio | 7.1x |
Enterprise Valuation
Counting debt and cash, the company is valued at 7.6x EBITDA and 11.9x free cash flow.
| EV / Earnings | 16.8x |
|---|---|
| EV / Sales | 2.2x |
| EV / EBITDA | 7.6x |
| EV / EBIT | 11.3x |
| EV / FCF | 11.9x |
Price Statistics
The stock is up 10.62% over 52 weeks and trades 11.89% above its 50-day average.
| Beta (1Y) | 0.41 |
|---|---|
| 52-Week Change | +10.62% |
| 1-Month Change | +12.76% |
| 3-Month Change | +36.69% |
| 6-Month Change | +69.59% |
| 5-Year Change | +48.39% |
| 10-Year Change | +52.81% |
| Total Return (1Y) | +10.62% |
| Total Return (3Y CAGR) | -19.48% |
| Total Return (5Y CAGR) | +7.74% |
| Return vs SPY (1Y) | +1.07% |
| Max Drawdown (1Y) | -42.62% |
| Max Drawdown (3Y) | -73.41% |
| Sharpe Ratio (1Y) | 0.23 |
| Correlation with SPY (1Y) | 0.11 |
| 50-Day Average | $26.07 |
| 200-Day Average | $22.37 |
| 52-Week Range | $16.64 to $31.00 |
| RSI (14 Days) | 65.1 |
| Average Volume (20 Days) | 478.71K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.32x current liabilities, and total debt is 0.75x shareholder equity.
| Current Ratio | 3.32x |
|---|---|
| Quick Ratio | 2.36x |
| Debt / Equity | 0.75x |
| Debt / EBITDA | 2.83x |
| Debt / FCF | 4.41x |
| Interest Coverage | 5.52x |
Returns and Efficiency
Return on invested capital is 7.85% over the last 12 months, against a 5-year average of 12.31%.
| Return on Equity (ROE) | 12.15% |
|---|---|
| Return on Assets (ROA) | 5.78% |
| Return on Invested Capital (ROIC) | 7.85% |
| Return on Capital Employed (ROCE) | 9.59% |
| ROE (5Y Average) | 17.44% |
| ROA (5Y Average) | 9.39% |
| ROIC (5Y Average) | 12.31% |
| Asset Turnover | 0.44x |
| Inventory Turnover | 2.24x |
| Receivables Turnover | 4.56x |
| Cash Conversion Cycle | 50 days |
Taxes
Income tax took 23.63% of pretax income over the last 12 months.
| Income Tax (TTM) | $30.61M |
|---|---|
| Effective Tax Rate | 23.63% |
Scores
AMPH has an Altman Z-Score of 2.45, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.45 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $745.79M over the last 12 months is up 3.11% from the 12 months before.
| Revenue | $745.79M |
|---|---|
| Revenue Growth (YoY) | +3.11% |
| Gross Profit | $349.09M |
| Operating Income | $139.74M |
| Pretax Income | $129.57M |
| Net Income | $98.96M |
| EBITDA | $216.94M |
| EBIT | $146.78M |
| Reported EPS (TTM) | $2.84 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 47.63% of the $1.71B in total assets.
| Cash and Equivalents | $204.59M |
|---|---|
| Total Debt | $613.00M |
| Net Debt | $408.41M |
| Net Debt Per Share | $9.59 |
| Working Capital | $421.25M |
| Shareholder Equity | $814.55M |
| Book Value Per Share | $19.13 |
| Tangible Book Value | $174.13M |
| Tangible Book Per Share | $4.09 |
| Total Assets | $1.71B |
| Total Liabilities | $897.17M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $36.31M of capital spending, operating cash flow left $139.01M of free cash flow.
| Operating Cash Flow | $175.33M |
|---|---|
| Capital Expenditures | $36.31M |
| Free Cash Flow | $139.01M |
| FCF Per Share | $3.27 |
| Depreciation and Amortization | $70.16M |
| Share Repurchases | $95.66M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 18.74%, against a 5-year average of 23.13%.
| Gross Margin | 46.81% |
|---|---|
| Operating Margin | 18.74% |
| Pretax Margin | 17.37% |
| Net Margin | 13.27% |
| EBITDA Margin | 29.09% |
| EBIT Margin | 19.68% |
| FCF Margin | 18.64% |
| Gross Margin (5Y Average) | 50.10% |
| Operating Margin (5Y Average) | 23.13% |
| Net Margin (5Y Average) | 17.91% |
Growth
Revenue grew 12.99% a year over 3 years, and EPS 15.43% a year.
| Revenue Growth (3Y CAGR) | +12.99% |
|---|---|
| Revenue Growth (5Y CAGR) | +15.53% |
| EPS Growth (3Y CAGR) | +15.43% |
| EPS Growth (5Y CAGR) | +36.47% |
| FCF Growth (3Y CAGR) | +23.00% |
| FCF Growth (5Y CAGR) | +38.94% |
| Operating Income Growth (3Y CAGR) | +9.31% |
| Book Value Per Share Growth (2Y CAGR) | +17.76% |
| Tangible Book Per Share Growth (2Y CAGR) | +209.64% |
Dividends and Yields
AMPH does not pay a dividend. Its free cash flow yield is 11.19%.
| Earnings Yield | 9.71% |
|---|---|
| FCF Yield | 11.19% |
| Buyback Yield | 7.37% |
| Shareholder Yield | 7.37% |
Peer Position
Against 11 similar companies, AMPH has the 9th highest P/E.
P/E RatioPeer median 12.8x
P/S RatioPeer median 2.0x
ROICPeer median 11.64%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +19.68%
| P/E Ratio | 10.3x vs 12.8x median |
|---|---|
| P/S Ratio | 1.7x vs 2.0x median |
| ROIC | 7.85% vs 11.64% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +3.11% vs +19.68% median |
Analyst Forecast
Consensus estimates put revenue growth at 4.92% and EPS growth at -5.78% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +4.92% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -5.78% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About AMPH
What is AMPH's market cap?
Amphastar P has a market cap of $1.25B. Its enterprise value, which adds debt and subtracts cash, is $1.66B.
What is AMPH's P/E ratio?
Amphastar P has a trailing P/E ratio of 10.3x and a forward P/E of 9.0x.
How many shares of AMPH are outstanding?
Amphastar P has 42.58M shares outstanding. The count is down 8.38% from a year earlier.
Does AMPH pay a dividend?
No. Amphastar P does not pay a dividend.
How much debt does AMPH have?
Amphastar P has $613.00M of total debt and $204.59M of cash and equivalents, a net debt position of $408.41M.
AMPH pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors